Loading...
Loading...
By Sofía Garduño - Wed, 03/15/2023 - 11:00
Mexico has the capacity to attract US$500 million in investment for pharmaceutical innovation, says Rafael Gual, Director General of CANIFARMA.
Featured content
Thu, 04/11/2024 - 15:25
Current regulation in Mexico hinders the full development of healthcare markets, including cannabis and AI, says BPF’s Jaime Castro.
